Gastric perforation secondary to mucormycosis infection in a kidney-pancreas transplant patient. A fatal complication

被引:0
作者
Pascual, Franco R. [1 ]
Figueroa, Rodrigo [1 ]
Zanatta-Scattolini, Julieta [1 ]
Yance, Maximiliano [1 ]
Valenzuela, Carlos [1 ]
Traverso, Rogelio [1 ]
Gil, Octavio [1 ]
机构
[1] Sanatorio Allende, Serv Trasplante Hepat & Renopancreat, Cordoba, Argentina
来源
CIRUGIA Y CIRUJANOS | 2024年 / 92卷 / 06期
关键词
Mucormycosis; Pancreas Transplantation; Kidney Transplantation; Gastrectomy; INVASIVE FUNGAL-INFECTIONS; EPIDEMIOLOGY;
D O I
10.24875/CIRU.22000109
中图分类号
R61 [外科手术学];
学科分类号
摘要
Mucormycosis is a rare deep fungal infection that develops mainly in immunosuppressed patients, being unusual the gastrointestinal presentation. The adequate treatment consists in rapid and aggressive surgical debridement, along with initial adjuvant treatment with liposomal amphotericin B. Despite recent advances in the management of this disease, the prognosis is poor, with a high mortality rate. We will present a case of a 37-year-old male patient, who underwent a combined pancreas and kidney transplant, with gastric perforation secondary to deep mucormycosis.
引用
收藏
页码:814 / 817
页数:145
相关论文
共 13 条
  • [1] Prakash H, Chakrabarti A., Global epidemiology of mucormycosis, J Fungi (Basel), 5, (2019)
  • [2] Ambrosioni J, Bouchuiguir-Wafa K, Garbino J., Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors, Int J Infect Dis, 14, pp. e100-e103, (2010)
  • [3] Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, SC-A Chen, Et al., Contemporary management and clinical outcomes of mucormycosis: a systematic review and meta-analysis of case reports, Int J Antimicrob Agents, 53, pp. 589-597, (2019)
  • [4] Neofytos D, Fishman JA, Horn D, Anaissie E, Chang C-H, Olyaei A, Et al., Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients: invasive fungal infections in SOT, Transpl Infect Dis, 12, pp. 220-229, (2010)
  • [5] Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Et al., Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin Infect Dis, 50, pp. 1101-1111, (2010)
  • [6] Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Et al., Epidemiology and outcome of zygomycosis: a review of 929 reported cases, Clin Infect Dis, 41, pp. 634-653, (2005)
  • [7] Richardson M., The ecology of the Zygomycetes and its impact on environmental exposure, Clin Microbiol Infect, 15, pp. 2-9, (2009)
  • [8] Spellberg B, Edwards J, Ibrahim A., Novel perspectives on mucormycosis: pathophysiology, presentation, and management, Clin Microbiol Rev, 18, pp. 556-569, (2005)
  • [9] Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DCM, Et al., The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports, Clin Microbiol Infect, 25, pp. 26-34, (2019)
  • [10] Dioverti MV, Cawcutt KA, Abidi M, Sohail MR, Walker RC, Osmon DR., Gastrointestinal mucormycosis in immunocompromised hosts, Mycoses, 58, pp. 714-718, (2015)